You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 13, 2024

CYTOXAN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Cytoxan, and when can generic versions of Cytoxan launch?

Cytoxan is a drug marketed by Baxter Hlthcare and is included in two NDAs.

The generic ingredient in CYTOXAN is cyclophosphamide. There are nineteen drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the cyclophosphamide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Cytoxan

A generic version of CYTOXAN was approved as cyclophosphamide by BAXTER HLTHCARE on May 21st, 2008.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CYTOXAN?
  • What are the global sales for CYTOXAN?
  • What is Average Wholesale Price for CYTOXAN?
Drug patent expirations by year for CYTOXAN
Recent Clinical Trials for CYTOXAN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Pennsylvania Clinical Cell and Vaccine Production Facility (CVPF)Phase 1
National Institute of Allergy and Infectious Diseases (NIAID)Phase 1
University Cancer Research Fund at Lineberger Comprehensive Cancer CenterPhase 1/Phase 2

See all CYTOXAN clinical trials

US Patents and Regulatory Information for CYTOXAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare CYTOXAN cyclophosphamide INJECTABLE;INJECTION 012142-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Baxter Hlthcare CYTOXAN (LYOPHILIZED) cyclophosphamide INJECTABLE;INJECTION 012142-005 Aug 30, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Baxter Hlthcare CYTOXAN cyclophosphamide TABLET;ORAL 012141-001 Approved Prior to Jan 1, 1982 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Baxter Hlthcare CYTOXAN (LYOPHILIZED) cyclophosphamide INJECTABLE;INJECTION 012142-009 Dec 10, 1985 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Baxter Hlthcare CYTOXAN cyclophosphamide INJECTABLE;INJECTION 012142-002 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.